This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Repros To Webcast Investor And Analyst Day On June 6th

THE WOODLANDS, Texas, June 3, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. ® (Nasdaq:RPRX) today announced that it will host a live webcast of its Investor and Analyst Day that is being held in New York on Thursday, June 6, 2013 beginning at 12:00 p.m. Eastern Time.

Key Opinion Leaders will discuss the positive data from the 1 st completed Phase III study with Androxal ®, ZA-301, and the significance of data from the AUA podium session. The focus of the participating inter-disciplinary group will be the role of Androxal in "managing the whole patient". In addition there will be a short overview of the Proellex ®-V program.

Presenters include:

  • Michael G Wyllie, Ph.D., DSc. - Director of the Company
  • Andrew McCullough, M.D. - Professor of Urology/Division of Surgery, Albany Medical College: Urological Inst of North Eastern NY
  • John Dean, M.D. - Immediate past president of the International Society of Sexual Medicine, Harley St, London, UK
  • Larry Lipshultz, M.D. - Professor of Urology and Chief of the Division of Male Reproductive Medicine and Surgery at the Baylor College of Medicine in Houston, Texas
  • Edward Kim, Ph.D. – Professor at University of Tennessee Graduate School of Medicine
  • Glenn Cunningham, M.D. - Professor of Medicine and Molecular & Cellular Biology Baylor College of Medicine, Director, SLEH-BCM Diabetes Program
  • Andrew Dwyer - Project Department of Endocrinology, Diabetes and Metabolism Centre Hospitalier Universitaire Vaudois
  • Nelly Pitteloud, M.D. - Professor of Medicine, Co-Chief, Endocrinology, Diabetes and Metabolism Service, CHUV, Lausanne, Switzerland
  • Alfred Poindexter, M.D. - board certified physician and professor in the Department of Obstetrics and Gynecology at Baylor College of Medicine
  • Joachim F. Wernicke, Ph.D., M.D. – CMO of Repros
  • Jaye Thompson, Sr. VP Clinical & Regulatory of Repros

A live and archived webcast of the presentation will be available on the " Events" section of the Company's website, http://www.reprosrx.com .

About Repros Therapeutics Inc.

Repros Therapeutics focuses on the development of small molecule drugs for major unmet medical needs that treat male and female reproductive disorders.

Stock quotes in this article: RPRX 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,412.61 -12.24 -0.07%
S&P 500 1,862.76 +0.45 0.02%
NASDAQ 4,087.8960 +1.6710 0.04%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs